Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone?secreting pituitary adenomas

被引:6
|
作者
Kim, Soo Heon [1 ]
Ku, Cheol Ryong [2 ,3 ,4 ]
Na, Minkyun [1 ]
Yoo, Jihwan [1 ]
Kim, Woohyun [1 ]
Jung, In-Ho [1 ]
Kim, Kyung Won [2 ]
Moon, Ju Hyung [1 ,3 ,4 ]
Kim, Daham [2 ,3 ,4 ]
Lee, Eun Jig [2 ,3 ,4 ]
Kim, Sun Ho [1 ,5 ]
Kim, Eui Hyun [1 ,3 ,4 ]
机构
[1] Yonsei Univ, Dept Neurosurg, Coll Med, Seoul, South Korea
[2] Yonsei Univ, Dept Internal Med, Div Endocrinol & Metab, Coll Med, Seoul, South Korea
[3] Severance Hosp, Pituitary Tumor Ctr, Seoul, South Korea
[4] Yonsei Univ, Yonsei Endocrine Res Inst, Coll Med, Seoul, South Korea
[5] Ewha Womans Univ, Dept Neurosurg, Coll Med, Seoul, South Korea
关键词
hyperthyroidism; pituitary adenoma; remission; thyroid-stimulating hormone; transsphenoidal surgery; pituitary surgery;
D O I
10.3171/2020.1.JNS192787
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Thyroid-stimulating hormone (TSH)-secreting pituitary adenoma (TSHoma) is a rare type of pituitary adenoma; thus, little is known about TSHomas. The purpose of this study was to analyze clinical characteristics and therapeutic outcomes of TSHomas based on a single-center experience. The authors also searched for reliable preoperative and early postoperative factors that could predict long-term endocrinological remission. METHODS The clinical, radiological, and pathological characteristics and surgical and endocrinological outcomes of 31 consecutive cases of TSHomas that were surgically treated between 2005 and 2017 were reviewed retrospectively. Preoperative factors were evaluated for their ability to predict long-term remission by comparing remission and non remission groups. TSH and free thyroxine levels were measured at 2, 6, 12, 18, and 24 hours after surgery to determine whether they could predict long-term remission. RESULTS Gross-total removal of tumor was achieved in 28 patients (90.3%), and 26 patients (83.9%) achieved endocrinological remission by surgery alone based on long-term endocrinological follow-up (median 50 months, range 32-81 months). The majority of the tumors were solid (21/31, 67.7%), and en bloc resection was possible in 16 patients (51.6%). Larger tumor size and tumor invasion into cavernous sinus and sphenoid sinus were strong predictors of lower rates of endocrinological remission. Immediate postoperative TSH level at 12 hours after surgery was the strongest predictor, with a 0.62 mu IU/mL cutoff. Postoperative complications included CSF rhinorrhea in one patient and epistaxis in another patient, who underwent additional surgical treatment for the complications. CONCLUSIONS Tumor size and extent are major prognostic factors for both extent of resection and endocrinological remission. The consistency of TSHomas was more likely to be solid, which makes extracapsular dissection more feasible. Long-term remission of TSHomas could be predicted even during the early postoperative period. https://thejns.org/doi/abs/10.3171/2020.1.JNS192787
引用
收藏
页码:794 / 800
页数:7
相关论文
共 50 条
  • [41] Bispecific-Ab-based immunoassay of thyroid-stimulating hormone
    Kuniyo Inouye
    Cancer Immunology, Immunotherapy, 1997, 45 : 159 - 161
  • [42] Preconception thyroid-stimulating hormone levels and adverse pregnancy outcomes
    Li, Min
    He, Yang
    Mao, Yanyan
    Yang, Liu
    Chen, Liang
    Du, Jing
    Chen, Qing
    Zhu, Qianxi
    Liu, Jun
    Zhou, Weijin
    CLINICAL ENDOCRINOLOGY, 2022, 97 (03) : 339 - 346
  • [43] Data mining: Seasonal and temperature fluctuations in thyroid-stimulating hormone
    Wang, Danchen
    Cheng, Xinqi
    Yu, Songlin
    Qiu, Ling
    Lian, Xiaolan
    Guo, Xiuzhi
    Hu, Yingying
    Lu, Shuangyu
    Yang, Guohua
    Liu, Huaicheng
    CLINICAL BIOCHEMISTRY, 2018, 60 : 59 - 63
  • [44] Thyroid-Stimulating Hormone Values in Pregnancy: Cutoff Controversy Continues?
    Suvarna Khadilkar
    The Journal of Obstetrics and Gynecology of India, 2019, 69 : 389 - 394
  • [45] The Impact of Seasonal Changes on Thyroxine and Thyroid-Stimulating Hormone in Newborns
    McMahon, Rebecca
    DeMartino, Lenore
    Sowizral, Mycroft
    Powers, Diana
    Tracy, Melissa
    Caggana, Michele
    Tavakoli, Norma P.
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2021, 7 (01)
  • [46] Thyroid-Stimulating Hormone Receptor: the Role in the Development of Thyroid Pathology and Its Correction
    Fokina, E. F.
    Shpakov, A. O.
    JOURNAL OF EVOLUTIONARY BIOCHEMISTRY AND PHYSIOLOGY, 2022, 58 (05) : 1439 - 1454
  • [47] Thyroid-Stimulating Hormone Receptor: the Role in the Development of Thyroid Pathology and Its Correction
    E. F. Fokina
    A. O. Shpakov
    Journal of Evolutionary Biochemistry and Physiology, 2022, 58 : 1439 - 1454
  • [48] Thyroid-Stimulating Hormone Testing and Outcomes in Total Laryngectomy Patients
    Warren, James D.
    Oglesby, Kacie R.
    Homan, Carlton R.
    Howe, Edmund
    Paul, Oishika
    Tassone, Patrick
    Kane, Anne C.
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2025,
  • [49] Levothyroxine Dosage Is Associated with Stability of Thyroid-stimulating Hormone Values
    Pecina, Jennifer
    Garrison, Gregory M.
    Bernard, Matthew E.
    AMERICAN JOURNAL OF MEDICINE, 2014, 127 (03): : 240 - 245
  • [50] Instability of harmonized thyroid-stimulating hormone immunoassays in clinical practice
    Uto, Kenichi
    Bando, Hironori
    Fukuoka, Hidenori
    Yamamoto, Masaaki
    Ogasahara, Ayako
    Ono, Shoko
    Oyabu, Chinami
    Sato, Itsuko
    Imanishi, Takamitsu
    Saegusa, Jun
    Ogawa, Wataru
    Yano, Yoshihiko
    CLINICAL ENDOCRINOLOGY, 2023, 99 (02) : 217 - 227